Hyderabad, Apr 4 (TNT): A Chintan Shivir organised by the Pharmaceutical Export Promotion Council of India (PHARMEXCIL) in Hyderabad outlined a strategic vision to position India as a global benchmark for pharmaceutical quality and reliability.
The event, held with the support of the Ministry of Commerce and Industry, brought together policymakers, industry leaders and experts to deliberate on strengthening India’s pharmaceutical export ecosystem.
Union Commerce Secretary Rajesh Agrawal, who chaired the inaugural session, emphasised the need for policy support, regulatory alignment and digital transformation to reinforce India’s leadership in global pharmaceutical exports.
He highlighted that India’s pharma sector is well-positioned to move towards high-value segments such as biologics and biosimilars, while strengthening its reputation for quality and reliability.
Pharmexcil Chairman Namit Joshi said that despite global challenges such as supply chain disruptions and geopolitical tensions, India’s export sector remains resilient with positive growth trends.
Director General of Pharmexcil Raja Bhanu said pharmaceutical exports reached about USD 28.29 billion during April–February FY26, registering a 5.6 per cent growth year-on-year. He added that the sector, currently valued at around USD 60 billion, is projected to reach USD 130 billion by 2030.
The deliberations covered key areas such as the role of artificial intelligence and digital transformation in regulatory processes, utilisation of Free Trade Agreements (FTAs), and strategies to enhance export competitiveness and market access.
Participants also discussed the importance of strengthening regulatory frameworks, reducing procedural bottlenecks and supporting MSMEs to expand India’s footprint in global markets.
The Shivir also highlighted Hyderabad as a major pharmaceutical hub, contributing significantly to India’s drug manufacturing and exports, particularly in bulk drugs, generics and biosimilars.
The event concluded with a consensus on the need for continued collaboration between the government and industry to achieve India’s ambitious pharmaceutical export growth targets.
TNT TS
Leave a Reply